Thrivent Financial for Lutherans’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.84M | Sell |
245,253
-230,572
| -48% | -$8.31M | 0.02% | 601 |
|
|
2025
Q1 | $14.8M | Hold |
475,825
| – | – | 0.03% | 460 |
|
|
2024
Q4 | $12.1M | Buy |
475,825
+132,675
| +39% | +$3.38M | 0.02% | 599 |
|
|
2024
Q3 | $9.71M | Buy |
343,150
+168,905
| +97% | +$4.78M | 0.02% | 686 |
|
|
2024
Q2 | $4.6M | Buy |
174,245
+154,408
| +778% | +$4.07M | 0.01% | 933 |
|
|
2024
Q1 | $602K | Hold |
19,837
| – | – | ﹤0.01% | 2158 |
|
|
2023
Q4 | $557K | Sell |
19,837
-1,740
| -8% | -$48.9K | ﹤0.01% | 2168 |
|
|
2023
Q3 | $585K | Sell |
21,577
-2,640
| -11% | -$71.6K | ﹤0.01% | 2059 |
|
|
2023
Q2 | $744K | Buy |
+24,217
| New | +$744K | ﹤0.01% | 1986 |
|